Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 210 for “"BCR-ABL"”.
-
TARGETED COVALENT REVERSIBLE BCR-ABL INHIBITORS
… catalytic lysine-targeting reversible covalent BCR-ABL inhibitors with single-digit nanomolar potency against both wild type, and mutant ABL proteins using the carbonyl boronic acid warhead is reported. It is shown that the evolutionarily conserved lysine can be targeted selectively using mass …
-
Optimizing immunity against BCR-ABL positive leukemia
… by proliferation of cells expressing BCR-ABL fusion proteins. The BCR-ABL fusion proteins are tumor-specific antigens and represent reasonable targets for immunologic approaches against CML. We have utilized a free-solution-isoelectric focusing technique (FS-IEF) to obtain chaperone …
-
Src-Kinasen als Mediatoren Bcr-Abl-induzierter Leukämien
Bcr-Abl, eine onkogene Tyrosinkinase, ist maßgeblich an der Entstehung der chronischen myeloischen Leukämie (CML) sowie einem Teil der Fälle von akuter B-lymphoblastischer Leukämie (B-ALL) beteiligt. Die essentielle Rolle der Kinase-Aktivität von Bcr-Abl für dessen leukämogenes Potential konnte in …
-
Antisense BCR-ABL oligonucleotides in chronic myeloid leukemia
Dept. of Hematology University Hospital Nijmegen, 09 oktober 1997
-
EGR-1 TUMOR SUPPRESSOR IN BCR-ABL DRIVEN LEUKEMIA
… cure CML make it important that new therapy capable of effectively curing it be developed. The early growth response-1 (Egr-1) gene is a zinc-finger transcription factor localized to the human chromosome 5. Egr-1 belongs to a family of early response genes whose expression is rapidly stimulated …
-
Reprogramming of myeloid progenitors by the BCR-ABL oncogene
The constitutive tyrosine kinase activity of the BCR-ABL oncogene is central for the pathogenesis of chronic myeloid leukaemia (CML). Clinical treatment of CML with the kinase inhibitor Imatinib Mesylate (IM) is a fundamental success demonstrating disease addiction upon BCR-ABL activity. However, …
-
Regulation of BCR-ABL expression via its 3’untranslated region.
… between chromosomes 9 and 22 fuses the BCR gene with the ABL1 gene, and gives rise to the BCR-ABL gene. Expression of the BCR-ABL protein initiates and drives CML. The level of BCR-ABL expression is associated with disease progression and response to therapy, yet control of BCR-ABL …
-
Role Of Gadd45a In BCR-ABL and NRASD12 Driven Leukemia
BCR-ABL is known as the most common translocation in the myeloproliferative (MPD) disorder chronic myelogenous leukemia (CML); it is the first leukemia to be described and associated with a consistent cytogenetic abnormality, termed the Philadelphia chromosome (Ph1). Ph1 is a shortened chromosome …
-
ΜΕΛΕΤΗ ΤΟΥ ΧΙΜΑΙΡΙΚΟΥ ΓΟΝΟΥ BCR/ABL ΣΤΗ ΧΡΟΝΙΑ ΜΥΕΛΟΓΕΝΗ ΛΕΥΧΑΙΜΙΑ
… DOUBLE: FIRST, THE (PCR) MOLECULAR DETECTION OF BCR/ABL REARRANGEMENT (FUSION), BY USING BIOTINYLATED OLIGONUCLEOTIDES, INSTEAD OF P LABELED OLIGOS, IN THE HYBRIDIZATION OF PCR PRODUCTS. SECOND, THE CORRELATION BETWEEN CLINICAL FEATURES AND MOLECULAR TYPE OF BCR/ABL REARRANGEMENT (FUSION). 15 CML …
-
Dissecting BCR-ABL Variant Signaling Pathways Using Novel Interactome Identification Strategies
… goals of this study are (1) to understand how BCR-ABL variants differentially signal to produce different clinical/experimental phenotypes and (2) to develop novel interactome detection strategies to understand signaling. This dissertation describes an integrated approach of the use of …
-
The role of Ahi-1 and BCR-ABL in leukemic transformation
… in the presence and absence of p210[superscript]BCR-ABL), I compared both the biological and biochemical properties of several cloned lines of BaF/3 cells that had been transduced with either BCR-ABL or Ahi-1 or both control vectors. Overexpression of Ahi-1 mimicked the effect of BCR-ABL in …
-
How point mutations confer resistance in BCR-ABL: a computational study
Imatinib is a first generation BCR-Abl tyrosine kinase inhibitor widely used in the treatment of CML. A significant cause of relapse in patients receiving imatinib therapy can be attributed to the development of point mutations in the BCR-Abl tyrosine kinase and resulting imatinib-resistance. …
-
Localisation, activity and targeting of Bcr-Abl in chronic myeloid leukaemia
… characterised by the Philadelphia chromosome and Bcr-Abl oncoprotein which is a constitutively activated tyrosine kinase that is causative in CML. Treatment of CML was revolutionized by tyrosine kinase inhibitors (TKIs) in the last decade. TKIs target Bcr-Abl and block its tyrosine kinase …
-
The analysis of Bcr-Abl—Nox signalling in chronic myeloid leukaemia
… following generation of the chimeric protein Bcr-Abl, a constitutively active tyrosine kinase which induces oncogenesis in part by promoting increased cell survival and proliferation. Since the development of Bcr-Abl-specific tyrosine kinase inhibitors (TKIs) there has been a substantial …
-
Phosphorylation of Beclin 1 by BCR-ABL suppresses autophagy in CML
… constitutively active chimeric tyrosine kinase BCR-ABL is critical for initiation, progression and maintenance of chronic myelogenous leukemia (CML). Imatinib and second-generation BCR-ABL tyrosine kinase inhibitors (TKIs) serve now as standard therapies for Ph+ patients. However, disease …
-
Exploring BCR-ABL-independent mechanisms of TKI-resistance in chronic myeloid leukaemia
… currently no other drug treatment options available for these patients. Therefore, our aim was to identify and target alternative survival pathways against BCR-ABL in order to eradicate TKI-resistant cells. To investigate alternative survival mechanisms in TKI-resistant CML cells, …
-
Änderung der Stoffwechselaktivität von BaF3-Zellen durch die Expression von BCR/ABL
… durch die Expression von BCR/ABL bei BaF3-Zellen, einer murinen, IL-3-abhängigen B-Zelllinie. Die Zellen wurden in nährstoffreichem Standard- und in durch Titrationen ermittel-tem nährstoffarmem Minimalmedium auf unterschiedliche Stoffwechselaktivität in Abhän-gigkeit von …
-
Identification of BCR/ABL-negative hematopoietic progenitor cells within chronic myeloid leukemia marrow
This document only includes an excerpt of the corresponding thesis or dissertation. To request a digital scan of the full text, please contact the Ruth Lilly Medical Library's Interlibrary Loan Department (rlmlill@iu.edu).
Page 1 of 11